How do domestic patients purchase Revumenib?

As of2025, Revumenib (Revumenib, trade name: Revuforj) has not been officially launched in mainland China. Therefore, if domestic patients need to use this drug, they need to go through the following channels:

1.Purchase through formal overseas channels: Patients can purchase Revemenib through legal overseas drug procurement channels. These channels usually include overseas pharmacies, international medical institutions or cross-border e-commerce platforms. Before purchasing, patients are advised to consult a professional doctor to ensure that the medicine is suitable for their condition and to understand relevant customs policies and taxes.

2.Purchase in Hong Kong: Revimenib is already on the market in Hong Kong, and patients can purchase it through regular pharmacies in Hong Kong. Due to the differences in medical policies and regulations between Hong Kong and mainland China, patients should understand the relevant legal regulations before purchasing and ensure the legality of the purchasing channel and the authenticity of the drugs.

3.Participate in clinical trials: Patients can also get the opportunity to use the drug by participating in clinical trials of Revimeni. Clinical trials are usually organized by medical institutions or pharmaceutical companies, and patients need to meet specific inclusion criteria. Before participating in a clinical trial, patients should understand the purpose, process, possible risks and benefits of the trial in detail, and make decisions under the guidance of professional doctors.

4.Pay attention to domestic marketing progress: As the marketing application of Revimanib in mainland China gradually advances, patients should pay attention to the latest information released by the National Medical Products Administration (NMPA) and relevant medical institutions. Once the drug is approved, patients will have access to the drug through medical insurance reimbursement and other channels, thereby reducing their financial burden.

In short, if domestic patients need to use Revemenib, they should do so through legal channels and under the guidance of professional doctors. At the same time, patients should pay attention to the domestic launch progress of this drug in order to obtain relevant information in a timely manner.

Reference materials:https://www.drugs.com/